Aislamiento del virus linfotrópico de células T humano tipo I de un paciente con paraparesia espástica tropical: primer reporte en Cuba

Navea Leyva, Leonor; Dubed Echevarría, Marta; Álvarez Seguí, Giselle; Blanco de Armas, Madeline; Díaz Herrera, Felipe; Beguerías Santos, Ramón; Manuel Díaz Torres, Héctor.
Rev. cuba. med. trop ; 60(2)mayo-ago. 2008. graf, ilus
Artigo em Espanhol | LILACS | ID: lil-506356

Documentos relacionados

  1. Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP.
  2. Aislamiento del virus linfotrópico de células T humano tipo I de un paciente con paraparesia espástica tropical: primer reporte en Cuba
  3. First Description of Seronegative HTLV-1 Carriers in Argentina.
  4. Abnormal vitamin D and lipid profile in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
  5. HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.
  6. Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.
  7. Rapid onset and progression of myelopathy following an STI: a case for screening?
  8. Indigenous tropical spastic paraparesis in Madrid (Spain). Experience on screening of human T-lymphotropic virus.
  9. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
  10. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.